Desmoteplase
N/A
Report date: 2022/07/04 19:38:02
Base Information
Drug NameDesmoteplase
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[32]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesPaion Deutschland GmbhH. Lundbeck A/SForest Laboratories Inc +[4]
Active IndicationsN/A
Inactive Indications